FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4226383453> ?p ?o ?g. }

• W4226383453 endingPage "1319" @default.
• W4226383453 startingPage "1311" @default.
• W4226383453 abstract "Reduced intensity conditioning (RIC) and reduced toxicity conditioning (RTC) regimens enable allogeneic hematopoietic stem cell transplantation (alloSCT) to more patients due to reduction in transplant-related mortality (TRM). The conditioning regimens with fludarabine and treosulfan (Flu/Treo) or fludarabine, amsacrine, cytarabine (FLAMSA)-RIC have shown their efficacy and tolerability in various malignancies. So far, no prospective study comparing the two regimens is available. Two studies compared the regimens retrospectively, in which both provided similar outcome. In this retrospective, single-center analysis, these two regimens were compared with regard to outcome, rate of acute and chronic graft versus host disease (GvHD), and engraftment. 113 consecutive patients with myeloid malignancies who received Flu/Treo or FLAMSA-RIC conditioning prior to alloSCT between 2007 and 2019 were included. Except for age, previous therapies, and remission status before alloSCT, patient characteristics were well balanced. The median follow-up time within this analysis was 44 months. There was no significant difference in absolute neutrophil count (ANC) or platelet engraftment between the two conditioning regimens. Overall survival (OS), the relapse-free survival (RFS), and the TRM were not significantly different between the two cohorts. The rate of GvHD did not differ between the two groups. In summary, this retrospective analysis shows that there is no major difference regarding tolerability and survival between the Flu/Treo and FLAMSA-RIC regimens. Despite several limitations due to uneven distribution concerning age and remission status, we demonstrate that Flu/Treo and FLAMSA-RIC provide similar outcomes and are feasible in older and intensively pre-treated patients." @default.
• W4226383453 created "2022-05-05" @default.
• W4226383453 creator A5003690611 @default.
• W4226383453 creator A5007637367 @default.
• W4226383453 creator A5012026477 @default.
• W4226383453 creator A5028510513 @default.
• W4226383453 creator A5029932603 @default.
• W4226383453 creator A5059538708 @default.
• W4226383453 creator A5066615327 @default.
• W4226383453 creator A5071466038 @default.
• W4226383453 creator A5073761596 @default.
• W4226383453 creator A5086857428 @default.
• W4226383453 date "2022-04-01" @default.
• W4226383453 modified "2023-09-26" @default.
• W4226383453 title "Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis" @default.
• W4226383453 cites W1780724089 @default.
• W4226383453 cites W187238933 @default.
• W4226383453 cites W1977470787 @default.
• W4226383453 cites W1984432386 @default.
• W4226383453 cites W2023971040 @default.
• W4226383453 cites W2025428092 @default.
• W4226383453 cites W2046152217 @default.
• W4226383453 cites W2074326274 @default.
• W4226383453 cites W2079729552 @default.
• W4226383453 cites W2092673055 @default.
• W4226383453 cites W2097419847 @default.
• W4226383453 cites W2103529718 @default.
• W4226383453 cites W2106947293 @default.
• W4226383453 cites W2125695170 @default.
• W4226383453 cites W2127080762 @default.
• W4226383453 cites W2147773887 @default.
• W4226383453 cites W2152197116 @default.
• W4226383453 cites W2164277940 @default.
• W4226383453 cites W2379365975 @default.
• W4226383453 cites W24911164 @default.
• W4226383453 cites W2558118065 @default.
• W4226383453 cites W2558453831 @default.
• W4226383453 cites W2559537906 @default.
• W4226383453 cites W2590030902 @default.
• W4226383453 cites W2602192248 @default.
• W4226383453 cites W2618073389 @default.
• W4226383453 cites W2772882570 @default.
• W4226383453 cites W2885723861 @default.
• W4226383453 cites W2941194618 @default.
• W4226383453 cites W2945945569 @default.
• W4226383453 cites W2979469227 @default.
• W4226383453 cites W3006737210 @default.
• W4226383453 cites W4246085869 @default.
• W4226383453 doi "https://doi.org/10.1007/s00277-022-04822-x" @default.
• W4226383453 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35364726" @default.
• W4226383453 hasPublicationYear "2022" @default.
• W4226383453 type Work @default.
• W4226383453 citedByCount "0" @default.
• W4226383453 crossrefType "journal-article" @default.
• W4226383453 hasAuthorship W4226383453A5003690611 @default.
• W4226383453 hasAuthorship W4226383453A5007637367 @default.
• W4226383453 hasAuthorship W4226383453A5012026477 @default.
• W4226383453 hasAuthorship W4226383453A5028510513 @default.
• W4226383453 hasAuthorship W4226383453A5029932603 @default.
• W4226383453 hasAuthorship W4226383453A5059538708 @default.
• W4226383453 hasAuthorship W4226383453A5066615327 @default.
• W4226383453 hasAuthorship W4226383453A5071466038 @default.
• W4226383453 hasAuthorship W4226383453A5073761596 @default.
• W4226383453 hasAuthorship W4226383453A5086857428 @default.
• W4226383453 hasBestOaLocation W42263834531 @default.
• W4226383453 hasConcept C126322002 @default.
• W4226383453 hasConcept C141071460 @default.
• W4226383453 hasConcept C143998085 @default.
• W4226383453 hasConcept C167135981 @default.
• W4226383453 hasConcept C194409129 @default.
• W4226383453 hasConcept C197934379 @default.
• W4226383453 hasConcept C2776694085 @default.
• W4226383453 hasConcept C2776755627 @default.
• W4226383453 hasConcept C2777408962 @default.
• W4226383453 hasConcept C2778375690 @default.
• W4226383453 hasConcept C2779178397 @default.
• W4226383453 hasConcept C2779263901 @default.
• W4226383453 hasConcept C2780073493 @default.
• W4226383453 hasConcept C2780611847 @default.
• W4226383453 hasConcept C2911091166 @default.
• W4226383453 hasConcept C71924100 @default.
• W4226383453 hasConceptScore W4226383453C126322002 @default.
• W4226383453 hasConceptScore W4226383453C141071460 @default.
• W4226383453 hasConceptScore W4226383453C143998085 @default.
• W4226383453 hasConceptScore W4226383453C167135981 @default.
• W4226383453 hasConceptScore W4226383453C194409129 @default.
• W4226383453 hasConceptScore W4226383453C197934379 @default.
• W4226383453 hasConceptScore W4226383453C2776694085 @default.
• W4226383453 hasConceptScore W4226383453C2776755627 @default.
• W4226383453 hasConceptScore W4226383453C2777408962 @default.
• W4226383453 hasConceptScore W4226383453C2778375690 @default.
• W4226383453 hasConceptScore W4226383453C2779178397 @default.
• W4226383453 hasConceptScore W4226383453C2779263901 @default.
• W4226383453 hasConceptScore W4226383453C2780073493 @default.
• W4226383453 hasConceptScore W4226383453C2780611847 @default.
• W4226383453 hasConceptScore W4226383453C2911091166 @default.
• W4226383453 hasConceptScore W4226383453C71924100 @default.
• W4226383453 hasFunder F4320323383 @default.

• next